Fibromuscular dysplasia (FMD) of the arteries of the extremities has been reported few times in the literature. The clinical significance of FMD relates to the consequences of interruption of arterial blood to the tissues. We report here the second case of FMD of the brachial artery and discuss the failure of the calcium channel blocker, nifedipine, in the therapy of this disorder. A review of the pertinent literature is included.
Get full access to this article
View all access options for this article.
References
1.
Mettinger KL: Fibromuscular Dysplasia and the Brain II, Current Concepts of the Disease . Stroke13: 53-58, 1982.
Garrett HE, Hodosh S., DeBakey ME: Fibromuscular Hyperplasia of the Left Axillary Artery. Arch Surg94: 737-738, 1967.
6.
McCready RA, et al: Fibromuscular Dysplasia of the Right Subclavian Artery. Arch Surg117: 1243-1245, 1982.
7.
Sattiurai VS , Fry WJ, Stanley JC: Ultrastructure of Medial Smooth Muscle and Myofibroblasts in Human Arterial Dysplasia. Arch Surg113: 1280-1288, 1978.
8.
Kelly TF Jr, Morris GC Jr: Arterial Fibromuscular Disease. Observations on Pathogenesis and Surgical Management. Am J Surg143: 232-236, 1982.
9.
Stanley JC, et al: Arterial Fibrodysplasia-Histopathologic Character and Current Etiologic Concepts. Arch Surg110: 561-566, 1975.
10.
deMendonca WC, Espat PA: Pheochromacytoma Associated with Arterial Fibromuscular Dysplasia. Am J Clin Pathol75: 749-754, 1981.
11.
Fallon JT: Pathology of Arterial Lesions Amenable to Percutaneous Transluminal Angioplasty . AJR135: 913-916, 1980.
12.
Perry MD: Fibromuscular Dysplasia. Surg Gynecol Obstet139: 97-104, 1974,
13.
McGoon MD: The Clinical Use of Verapamil. Mayo Clin Pro57: 495-510, 1982.
14.
Braunwald E. : Mechanism of Action of Calcium-Channel Blocking Agents. N Engl J Med307: 1618-1627, 1982 .
